Navigation Links
Par Pharmaceutical Reports Second Quarter 2008 Results
Date:8/7/2008

/p>

Revenues:

Net product sales $108,289 $160,014 $259,526 $382,603

Other product related

revenues 4,648 7,626 8,339 19,247

Total revenues 112,937 167,640 267,865 401,850

Cost of goods sold 87,829 111,085 193,236 257,606

Gross margin 25,108 56,555 74,629 144,244

Operating expenses:

Research and development 15,955 14,277 33,113 28,316

Selling, general and

administrative 36,690 33,999 68,037 66,556

Settlements, net - - - (578)

Total operating expenses 52,645 48,276 101,150 94,294

Gain on sale of product

rights and other (500) - (2,125) (20,000)

Operating (loss) income (27,037) 8,279 (24,396) 69,950

Other (expense) income, net - (30) - (49)

Equity in loss of joint

venture (310) (80) (330) (228)

Loss on marketable

securities and other

investments, net (433) (6,040) (433) (4,643)

Interest income 2,129 3,901 5,143 6,585

Interest expense (1,667) (1,727) (3,334) (3,445)

(Loss) income from

continuing operations

before provision for

income taxes (27,318) 4,303 (23,350) 68,170

(Benefit) provision for

income taxes (7,523) 1,505 (6,081) 23,858

(Loss) income from

continuing operations (19,795) 2,798 (17,269) 44,312

Discontinued operations:

Gain from discontinued

operations - -
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
2. Memory Pharmaceuticals to Announce Second Quarter 2008 Results on Wednesday, August 13, 2008
3. Watson Pharmaceuticals Reports Second Quarter 2008 Results
4. XTELL Launches its Commercial Biorepository Services for Research and Pharmaceutical Companies
5. Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results
6. Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights
7. Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
8. Prometic reaches understanding for commercialisation of several biopharmaceutical products and strategic investment
9. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Two Investment Conferences During the Month of August 2008
10. Kowa Company, Ltd. Acquires ProEthic Pharmaceuticals, Inc.
11. Lilly Reaffirms Purchase Offer for SGX Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 25 novembre 2014 /PRNewswrie/ -- Theravalues Corporation annuncia con ... europeo in occasione di Hi Europe 2014 (dal 2 ... Si tratta della curcumina con la maggiore biodisponibilità ... cristalli) e ingredienti approvati dalle norme europee. ... della pianta curcumina ( Curcuma longa ) che è ...
(Date:11/24/2014)... , Nov. 24, 2014  IGI Laboratories, Inc. ... based specialty generic pharmaceutical company, today announced it ... to the U.S. Food and Drug Administration (FDA), which ... 2014 to seven, with eighteen submissions now pending at ... President and CEO of the Company, commented, "Our team ...
(Date:11/24/2014)... 2014  Last week, Representatives Gus Bilirakis ... took a bold bipartisan step on behalf of ... Act. Original co-sponsors of the legislation include Representatives ... incentivize drug makers and innovators to "repurpose" major ... cancers, which opens the door to the development ...
(Date:11/24/2014)...   First published ... Elsevier , a world-leading provider of scientific, technical ... the launch of the latest title in the Current ... Food Science . Current ... new platform to keep up-to-date with the expanding volume of ...
Breaking Biology Technology:La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa 2La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa 3IGI Laboratories, Inc. Announces ANDA Submission 2OPEN Act Introduced to Repurpose Drugs for Rare Diseases 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 3
... University of California, Berkeley, have developed a pressure-sensitive electronic ... new meaning to the term "thin-skinned." "The ... the human skin, which means incorporating the ability to ... of electrical engineering and computer sciences and head of ...
... Spotlights Innovations During ESTRO29 -- VEENENDAAL, The Netherlands, September 10, 2010 ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
... lure of greater profits elsewhere in the world may ... and distribution of affordable drugs, vaccines and diagnostics for ... millions of poor people, experts warn. And they ... support for continuing the success of firms finding homegrown ...
Cached Biology Technology:Engineers make artificial skin out of nanowires 2Engineers make artificial skin out of nanowires 3Nucletron Spotlights Innovations During ESTRO29 2Nucletron Spotlights Innovations During ESTRO29 3Nucletron Spotlights Innovations During ESTRO29 4Nucletron Spotlights Innovations During ESTRO29 5Nucletron Spotlights Innovations During ESTRO29 6Nucletron Spotlights Innovations During ESTRO29 7Global health vs. global wealth: Looming choice for health firms in developing countries 2Global health vs. global wealth: Looming choice for health firms in developing countries 3Global health vs. global wealth: Looming choice for health firms in developing countries 4
(Date:11/4/2014)... – University of Utah engineers developed the first room-temperature ... produce electricity without needing to ignite the fuel. These ... electronics, off-grid power and sensors. , A study of ... Chemical Society journal ACS Catalysis . , Fuel ... between a fuel and an oxygen-rich source such as ...
(Date:11/4/2014)... study examining only marketing directed at children on ... has found that the majority of black, middle-income ... marketing tactics. , Authored by Arizona State University ... is the first to examine the use of ... fast food restaurants and its relationship to demographics. ...
(Date:11/3/2014)... , Nov. 3, 2014 Research and Markets ... "Cell Therapy - Technologies, Markets and Companies" to their ... therapy technologies and methods, which have already started to play ... cell transplantation is replacing the old fashioned bone marrow transplants. ... therapy is bound to become a part of medical practice. ...
Breaking Biology News(10 mins):Jet-fueled electricity at room temperature 2Fast food marketing for children disproportionately affects certain communities 2Fast food marketing for children disproportionately affects certain communities 3Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 2Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 3
... Scientists at Joslin Diabetes Center have identified biological mechanisms ... against kidney disease, and also mechanisms that inhibit its ... online by Diabetes, may lead to the development of ... to prevent the harmful effects of hyperglycemia on renal ...
... melanoma is a malignant form of skin cancer and ... there is. Treatment is particularly difficult, because melanomas are ... Chris Marine, (VIB/KU Leuven) have found a new line ... cancers, namely by combating the interaction between the protein ...
... observes a colorful jellyfish pulsating through the ocean, Greek ... animal once was known as the medusa, after the ... gaze turned people into stone, and now, thanks to ... researchers at the California Institute of Technology (Caltech) and ...
Cached Biology News:Joslin researchers gain new understanding of diabetes and kidney disease 2Joslin researchers gain new understanding of diabetes and kidney disease 3New line of approach for combination therapy against melanoma 2Medusa reimagined: Caltech-led team reverse engineers a jellyfish with the ability to swim 2Medusa reimagined: Caltech-led team reverse engineers a jellyfish with the ability to swim 3Medusa reimagined: Caltech-led team reverse engineers a jellyfish with the ability to swim 4
Request Info...
Purified anti-eIF-4E...
Peptide-affinity Purified Polyclonal Antibody to SMAD7 Peptide with sequence SSCPCWLEVIFNSR, from C Terminus of the protein sequence according to NP_005895....
Purified anti-PXR...
Biology Products: